STOCK TITAN

MGRM Form 3: Director Colleen Gray discloses 3,000 stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Monogram Technologies (MGRM) filed a Form 3 disclosing director Colleen Gray’s initial beneficial ownership. The filing lists options to acquire 3,000 shares of common stock at $4 per share, exercisable on 11/30/2030 and expiring on 11/30/2033.

The options are reported as direct ownership. The date of event requiring the statement was 11/30/2023.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Gray Colleen

(Last) (First) (Middle)
3913 TODD LANE

(Street)
AUSTIN TX 78744

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
11/30/2023
3. Issuer Name and Ticker or Trading Symbol
Monogram Technologies Inc. [ MGRM ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Options to acquire Common Stock 11/30/2030 11/30/2033 Common Stock 3,000 $4 D
Explanation of Responses:
/s/ Colleen Gray 10/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Monogram Technologies (MGRM) report in this Form 3?

A director, Colleen Gray, reported options to acquire 3,000 shares of common stock.

What is the exercise price of the reported options for MGRM?

The options have an exercise price of $4 per share.

When do the MGRM options become exercisable and when do they expire?

They are exercisable on 11/30/2030 and expire on 11/30/2033.

How is the ownership of these options reported for MGRM?

The options are reported as Direct (D) ownership.

What is the relationship of the reporting person to MGRM?

The reporting person, Colleen Gray, is a Director.

What is the date of the event requiring this Form 3 for MGRM?

The date of event requiring the statement is 11/30/2023.
Monogram Orthopaedics Inc

NASDAQ:MGRM

View MGRM Stock Overview

MGRM Rankings

MGRM Latest News

MGRM Latest SEC Filings

MGRM Stock Data

243.79M
18.47M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
AUSTIN